Business Context and Reporting Period
Company: Reinsurance Group of America, Inc. (RGA)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2001
Business Overview: RGA operates primarily in the life reinsurance sector across five geographic segments: U.S., Canada, Asia Pacific, Latin America, and Other Markets. The company provides traditional life reinsurance, asset-intensive reinsurance (annuities, corporate-owned life insurance), and financial reinsurance.
Key Financial Metrics
| Metric (in thousands) | Q1 2001 | Q1 2000 |
|---|---|---|
| Total Revenues | $493,655 | $402,134 |
| Net Premiums | $404,585 | $329,543 |
| Investment Income (Net) | $84,089 | $74,010 |
| Net Income | $21,642 | $20,422 |
| Diluted EPS (Continuing Ops) | $0.43 | $0.48 |
| Total Assets | $6,136,090 | $6,061,860 (Dec 31, 2000) |
| Long-term Debt | $281,787 | $272,257 (Dec 31, 2000) |
| Cash & Equivalents | $123,264 | $70,797 (Dec 31, 2000) |
| Operating Cash Flow | $42,740 | $93,842 |
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 22.8% to $493.7 million, driven by a 22.8% increase in net premiums and a 13.6% increase in investment income.
- Profitability Decline: Despite revenue growth, income from continuing operations before taxes decreased 11.1% to $35.7 million. Net income increased only 6.0% due to higher pre-tax income in the prior year from discontinued operations.
- Segment Performance:
- U.S. Operations: Pre-tax income fell 10.9% to $30.3 million due to higher-than-expected death claims ($9 million excess) and increased realized investment losses.
- Canada Operations: Pre-tax income rose 40.2% to $17.1 million, largely due to $5.6 million in realized investment gains from portfolio realignment. Excluding these gains, income declined slightly.
- Other International: Reported a pre-tax loss of $4.6 million compared to a profit of $0.2 million in 2000. The loss was driven by higher claims on privatized pension business in Argentina.
- Cash Flow: Operating cash flow decreased significantly to $42.7 million from $93.8 million, primarily due to changes in reinsurance ceded balances and deferred policy acquisition costs.
Guidance, Outlook, and Risks
- Management Commentary: Management attributes the U.S. claim increase to specific long-standing treaties and does not view it as a systemic pricing issue. They expect mortality to remain constant long-term. Net premium growth in the U.S. remains strong (23.6% increase).
- Argentina Exposure: The company is monitoring adverse claim developments in Argentina related to privatized pension business, where claims are indexed to fund balances.
- Legal Proceedings: Several arbitrations are underway regarding group medical reinsurance. Management believes reserves are adequate and outcomes will not materially affect financial position.
- Market Risk:
- Interest Rate Risk: A hypothetical 300 basis point rise in rates would decrease the fair value of fixed-rate instruments by approximately $436.5 million (24.7%).
- Currency Risk: The company is exposed to foreign currency translation and transaction risks, particularly from the Canadian and Australian dollar devaluations observed in Q1 2001.
- Accounting Changes: Adoption of SFAS No. 138 resulted in a $0.5 million after-tax loss related to embedded derivatives.
Investor Verification Checklist
- Argentina Claims: Verify the trajectory of claims on privatized pension business in Argentina and the adequacy of current reserves.
- U.S. Mortality Trends: Monitor if the $9 million excess in death claims in Q1 2001 persists in subsequent quarters or remains an isolated event.
- Investment Portfolio: Review the composition of the $4.5 billion investment portfolio, specifically the $40.1 million in net unrealized losses on fixed maturity securities.
- Debt Covenants: Confirm compliance with covenants on the $140 million Credit Agreement and the $90 million outstanding balance.
- MetLife Concentration: Note that arrangements with MetLife and affiliates represented approximately 19.9% of pre-tax income from continuing operations in Q1 2001.